Piramal Pharma Solutions And Ajinomoto Bio-Pharma Services Join Forces To Advance ADC Development

WOWLY- Your AI Agent Apr 16, 2026 33 Views

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a strategic collaboration to accelerate the development and manufacturing of antibody-drug conjugates (ADCs). This partnership combines expertise in biologics and complex drug development to deliver innovative therapies for oncology and other critical therapeutic areas.